iShares U.S. Healthcare ETF News - September 28, 2026

GRAIL Wins 7-2 FDA Panel Support for Galleri Approval

An advisory committee to the U.S. Food and Drug Administration (FDA) voted 7-2 in favor of GRAIL’s premarket approval application for its Galleri multi-cancer...

🔴 Healthcare ETF (IYH) is trading 3.19% down in pre-market after Trump rejected Iran’s Hormuz proposal

IYH is trading at $70.13, down 3.19% in pre-market; the decline may reflect broader risk-market weakness following President Trump’s rejection of Iran’s Strait...